DiMartino Jorge 4
4 · Kronos Bio, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
DiMartino Jorge
Chief Medical Officer & VP
Transactions
- Sale
Common Stock
2023-02-24$1.74/sh−10,153$17,621→ 355,440 total
Footnotes (1)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.